Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.

Matrilin-2 (Matn2) is a multidomain adaptor protein which plays a role in the assembly of extracellular matrix (ECM). It is produced by oval cells during stem cell-driven liver regeneration. In our study, the impact of Matn2 on hepatocarcinogenesis was investigated in Matn2(-/-) mice comparing them...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexandra Fullár, Kornélia Baghy, Ferenc Deák, Bálint Péterfia, Yvonne Zsák, Péter Tátrai, Zsuzsa Schaff, József Dudás, Ibolya Kiss, Ilona Kovalszky
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e80dfd956d864a9686b67e0a730c2c23
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e80dfd956d864a9686b67e0a730c2c23
record_format dspace
spelling oai:doaj.org-article:e80dfd956d864a9686b67e0a730c2c232021-11-18T08:25:24ZLack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.1932-620310.1371/journal.pone.0093469https://doaj.org/article/e80dfd956d864a9686b67e0a730c2c232014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24691449/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Matrilin-2 (Matn2) is a multidomain adaptor protein which plays a role in the assembly of extracellular matrix (ECM). It is produced by oval cells during stem cell-driven liver regeneration. In our study, the impact of Matn2 on hepatocarcinogenesis was investigated in Matn2(-/-) mice comparing them with wild-type (WT) mice in a diethylnitrosamine (DEN) model. The liver tissue was analyzed macroscopically, histologically and immunohistochemically, at protein level by Proteome Profiler Arrays and Western blot analysis. Matn2(-/-) mice exhibited higher susceptibility to hepatocarcinogenesis compared to wild-type mice. In the liver of Matn2(-/-) mice, spontaneous microscopic tumor foci were detected without DEN treatment. After 15 μg/g body weight DEN treatment, the liver of Matn2(-/-) mice contained macroscopic tumors of both larger number and size than the WT liver. In contrast with the WT liver, spontaneous phosphorylation of EGFR, Erk1/2 GSK-3α/β and retinoblastoma protein (p-Rb), decrease in p21/CIP1 level, and increase in β-Catenin protein expression were detected in Matn2(-/-) livers. Focal Ki-67 positivity of these samples provided additional support to our presumption that the lack of Matn2 drives the liver into a pro-proliferatory state, making it prone to tumor development. This enhanced proliferative capacity was further increased in the tumor nodules of DEN-treated Matn2(-/-) livers. Our study suggests that Matn2 functions as a tumor suppressor in hepatocarcinogenesis, and in this process activation of EGFR together with that of Erk1/2, as well as inactivation of GSK-3β, play strategic roles.Alexandra FullárKornélia BaghyFerenc DeákBálint PéterfiaYvonne ZsákPéter TátraiZsuzsa SchaffJózsef DudásIbolya KissIlona KovalszkyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 4, p e93469 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alexandra Fullár
Kornélia Baghy
Ferenc Deák
Bálint Péterfia
Yvonne Zsák
Péter Tátrai
Zsuzsa Schaff
József Dudás
Ibolya Kiss
Ilona Kovalszky
Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.
description Matrilin-2 (Matn2) is a multidomain adaptor protein which plays a role in the assembly of extracellular matrix (ECM). It is produced by oval cells during stem cell-driven liver regeneration. In our study, the impact of Matn2 on hepatocarcinogenesis was investigated in Matn2(-/-) mice comparing them with wild-type (WT) mice in a diethylnitrosamine (DEN) model. The liver tissue was analyzed macroscopically, histologically and immunohistochemically, at protein level by Proteome Profiler Arrays and Western blot analysis. Matn2(-/-) mice exhibited higher susceptibility to hepatocarcinogenesis compared to wild-type mice. In the liver of Matn2(-/-) mice, spontaneous microscopic tumor foci were detected without DEN treatment. After 15 μg/g body weight DEN treatment, the liver of Matn2(-/-) mice contained macroscopic tumors of both larger number and size than the WT liver. In contrast with the WT liver, spontaneous phosphorylation of EGFR, Erk1/2 GSK-3α/β and retinoblastoma protein (p-Rb), decrease in p21/CIP1 level, and increase in β-Catenin protein expression were detected in Matn2(-/-) livers. Focal Ki-67 positivity of these samples provided additional support to our presumption that the lack of Matn2 drives the liver into a pro-proliferatory state, making it prone to tumor development. This enhanced proliferative capacity was further increased in the tumor nodules of DEN-treated Matn2(-/-) livers. Our study suggests that Matn2 functions as a tumor suppressor in hepatocarcinogenesis, and in this process activation of EGFR together with that of Erk1/2, as well as inactivation of GSK-3β, play strategic roles.
format article
author Alexandra Fullár
Kornélia Baghy
Ferenc Deák
Bálint Péterfia
Yvonne Zsák
Péter Tátrai
Zsuzsa Schaff
József Dudás
Ibolya Kiss
Ilona Kovalszky
author_facet Alexandra Fullár
Kornélia Baghy
Ferenc Deák
Bálint Péterfia
Yvonne Zsák
Péter Tátrai
Zsuzsa Schaff
József Dudás
Ibolya Kiss
Ilona Kovalszky
author_sort Alexandra Fullár
title Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.
title_short Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.
title_full Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.
title_fullStr Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.
title_full_unstemmed Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3β pathways in vivo.
title_sort lack of matrilin-2 favors liver tumor development via erk1/2 and gsk-3β pathways in vivo.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/e80dfd956d864a9686b67e0a730c2c23
work_keys_str_mv AT alexandrafullar lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT korneliabaghy lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT ferencdeak lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT balintpeterfia lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT yvonnezsak lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT petertatrai lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT zsuzsaschaff lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT jozsefdudas lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT ibolyakiss lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
AT ilonakovalszky lackofmatrilin2favorslivertumordevelopmentviaerk12andgsk3bpathwaysinvivo
_version_ 1718421833357721600